首页> 外文期刊>Journal of bodywork and movement therapies >Do Calcium Activated Potassium Channels Control Proliferation of Myofibroblasts? Implications for Fibroproliferative Diseases
【24h】

Do Calcium Activated Potassium Channels Control Proliferation of Myofibroblasts? Implications for Fibroproliferative Diseases

机译:钙激活的钾通道可控制成肌纤维细胞的增殖吗?对纤维增生性疾病的影响

获取原文
获取原文并翻译 | 示例
       

摘要

E The calcium-activated K+ channel, KCa3.1, has an important function in Ca2+ signaling for maintaining a negative membrane potential, which provides an electrochemical gradient to drive Ca2+ influx. In fibroblasts this channel is up-regulated in a TGF-J3 dependent manner. The same TGF-p / SMAD signaling is increased in several fibroproliferative diseases, for example in kidney fibrosis [Grgic et al 2009], or Dupuytren's disease [Krause et al 2011 ]. This pathway is also found to be involved in chronic inflammatory autoimmune diseases, like diabetes type 1 and T-cell mediated colitis or multiple sclerosis. Blockage of KCa 3.1 in fibroblast can suppress myogenesis [Pena 2000] and in pancreatic cancer cell lines it can stop proliferation [Jager et al 2004]:
机译:E钙激活的K +通道KCa3.1在Ca2 +信号传导中具有重要功能,可维持负膜电位,从而提供电化学梯度来驱动Ca2 +流入。在成纤维细胞中,该通道以TGF-J3依赖性方式上调。在几种纤维增生性疾病中,例如在肾纤维化[Grgic等,2009]或Dupuytren病[Krause等,2011]中,相同的TGF-p / SMAD信号传导增加。还发现该途径与慢性炎性自身免疫疾病有关,例如1型糖尿病和T细胞介导的结肠炎或多发性硬化。在成纤维细胞中阻断KCa 3.1可以抑制肌生成[Pena 2000],在胰腺癌细胞系中可以阻止增殖[Jager et al 2004]:

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号